background
human
metapneumoviru
hmpv
preval
children
elderli
immunocompromis
individu
avail
epidemiolog
data
limit
object
develop
valid
realtim
pcr
method
hmpv
diagnosi
determin
percentag
hmpv
respiratori
specimen
commun
associ
outbreak
geograph
area
provid
epidemiolog
data
term
age
distribut
season
coinfect
studi
design
realtim
pcr
assay
design
detect
hmpv
lineag
b
prospect
test
hmpv
period
undertaken
result
realtim
pcr
sensit
specif
detect
lineag
hmpv
hmpv
detect
n
specimen
outbreak
n
test
hmpvposit
patient
rang
age
day
year
median
age
month
number
posit
sampl
peak
winter
month
decemb
januari
februari
high
rate
coinfect
note
sampl
test
conclus
hmpv
common
commun
associ
outbreak
includ
hmpv
routin
test
improv
etiolog
diagnosi
acut
respiratori
infect
human
metapneumoviru
hmpv
common
worldwid
distribut
includ
canada
bastien
et
al
hamelin
et
al
robinson
et
al
play
signific
role
respiratori
infect
diseas
detect
analysi
hmpv
cultur
antigen
test
prove
difficult
may
lack
sensit
compar
nucleic
acid
amplif
test
nat
boivin
et
al
gerna
et
al
van
den
hoogen
et
al
two
major
lineag
hmpv
lineag
repres
two
sublineag
boivin
et
al
van
den
hoogen
et
al
b
limit
sequenc
divers
observ
fusion
f
gene
make
good
target
detect
nat
agapov
et
al
galiano
et
al
kuyper
et
al
van
den
hoogen
et
al
b
winther
et
al
develop
realtim
pcr
amplif
detect
assay
hmpv
primer
hydrolysi
probe
target
f
gene
report
develop
valid
perform
hmpv
assay
well
observ
hmpv
season
upper
respiratori
specimen
includ
nasopharyng
sampl
includ
swab
fluid
throat
swab
nasal
specimen
lower
respiratori
specimen
includ
bronchial
tracheal
specimen
tissu
fluid
includ
biopsi
sampl
pleural
chest
pericardi
fluid
percentag
sampl
test
posit
calcul
base
total
n
affect
popul
coinfect
rate
associ
outbreak
specimen
submit
provinci
laboratori
public
health
provlab
respiratori
viru
test
januari
march
includ
main
analysi
studi
number
type
specimen
test
list
tabl
np
sampl
screen
initi
direct
fluoresc
antigen
dfa
influenza
b
parainfluenza
respiratori
syncyti
viru
rsv
prior
novemb
lower
respiratori
tract
specimen
test
hmpv
novemb
dfaneg
np
sampl
specimen
type
test
hmpv
respiratori
sampl
pretreat
l
maul
proteas
qiagen
mississauga
ontario
thermomix
eppendorf
westburi
new
york
c
rpm
min
specimen
clear
sampl
viscou
like
indic
high
cellprotein
content
l
proteas
use
viral
rna
extract
treat
sampl
use
nuclisen
extractor
durham
nc
usa
subsequ
easymag
autom
extractor
accord
manufactur
instruct
extract
nucleic
acid
elut
l
sampl
input
volum
l
tissu
sampl
extract
use
total
nucleic
acid
extract
protocol
tissu
specimen
use
qiaamp
kit
qiagen
accord
manufactur
instruct
primer
probe
design
studi
use
primer
express
appli
biosystem
abi
foster
citi
ca
usa
list
tabl
avail
f
gene
sequenc
genbank
juli
align
design
primer
amplifi
bp
region
f
gene
hmpv
lineag
b
virus
forward
revers
primer
lineag
respect
two
forward
primer
one
revers
primer
design
amplif
lineag
b
strain
univers
minor
groov
bind
probe
hmpvunifam
design
simultan
detect
lineag
hmpv
two
lineagespecif
probe
label
fam
vic
respect
also
design
use
detect
differenti
lineag
b
virus
realtim
multiplex
format
primer
probe
set
compar
four
predict
prototyp
sequenc
van
den
hoogen
et
al
b
genbank
access
no
ensur
lineag
would
amplifi
detect
use
assay
primer
synthes
univers
core
dna
servic
univers
calgari
alberta
canada
probe
synthes
abi
twostep
rtpcr
method
use
amplif
detect
hmpv
revers
transcript
step
perform
use
superscript
ii
tm
rnaseout
tm
invitrogen
ca
usa
master
mix
compos
dtt
final
concentr
total
dntp
nm
ng
random
hexam
u
rnaseout
tm
u
superscript
tm
ii
final
volum
l
five
microlitr
extract
rna
combin
l
master
mix
rt
step
perform
c
min
follow
enzym
inactiv
step
c
min
use
geneamp
pcr
system
abi
cdna
synthesi
pcr
perform
abi
prism
sequenc
detect
system
optic
tube
abi
use
l
cdna
sens
antisens
primer
lineag
aand
bspecif
probe
univers
probe
pcr
perform
use
taqman
univers
pcr
master
mix
abi
accord
manufactur
instruct
taqman
univers
amplif
protocol
primer
hmpvclonfor
hmpvclonrev
tabl
design
amplifi
bp
region
f
gene
includ
region
use
diagnost
amplif
detect
hmpv
lineag
b
separ
clone
gener
lineag
b
control
virus
control
virus
use
templat
clone
provid
dr
yan
li
nation
microbiolog
laboratori
winnipeg
mannitoba
canada
pcr
product
clean
use
qiaquick
pcr
purif
kit
qiagen
clone
pcr
vector
use
topo
ta
clone
kit
invitrogen
transform
one
shot
f
compet
escherichia
coli
cell
invitrogen
electropor
presenc
clone
insert
detect
pcr
use
forward
primer
revers
primer
provid
ta
clone
kit
presenc
orient
insert
confirm
sequenc
use
abi
prism
bigdy
termin
cycl
sequenc
kit
abi
prism
avant
genet
analyz
data
collect
softwar
sequenc
analyz
use
sequenc
analysi
softwar
bioedit
http
wwwmbioncsuedubioeditbioedithtml
plasmid
dna
linear
use
restrict
enzym
kpni
xhoi
dna
transcrib
use
ribomax
tm
express
promega
madison
wi
usa
synthes
hmpv
lineag
b
rna
vitro
transcrib
rna
spectrophotometr
quantifi
measur
absorb
nm
absorb
valu
use
calcul
copiesml
transcrib
rna
present
seri
eight
dilut
set
start
copiesreact
prequantifi
vitro
transcrib
rna
hmpv
lineag
b
test
carri
three
differ
day
eight
replic
assess
end
point
sensit
specif
assay
determin
test
high
copi
number
sampl
duplic
common
respiratori
pathogen
includ
influenza
viru
b
parainfluenza
viru
rsv
b
human
coronaviru
rhinoviru
type
adenoviru
type
chlamydophila
pneumonia
legionella
pneumophila
mycoplasma
pneumonia
reproduc
hmpv
rtpcr
evalu
two
consecut
run
two
posit
clinic
specimen
test
triplic
run
primer
hmpvclonfor
hmpvclonrev
use
amplifi
base
f
gene
randomli
select
posit
sampl
pcr
product
sequenc
describ
section
analyz
use
bioedit
phylogenet
tree
construct
use
megalign
modul
lasergen
dnastar
madison
wi
usa
multipl
sequenc
align
tree
gener
use
clustalw
default
align
paramet
sequenc
hmpv
lineag
genbank
genbank
genbank
genbank
van
den
hoogen
et
al
b
use
refer
comparison
spss
softwar
use
statist
analysi
data
associ
age
detect
hmpv
analyz
use
pearson
chisquar
analysi
probit
analysi
undertaken
determin
assay
limit
detect
confid
interv
studi
assess
assay
limit
detect
perform
use
vitro
transcrib
rna
prepar
clone
target
templat
lineag
b
virus
result
probit
analysi
limit
detect
ci
given
fig
limit
detect
copi
hmpv
lineag
vitro
transcrib
rna
copi
hmpv
lineag
b
vitro
transcrib
rna
test
univers
probe
limit
detect
copi
hmpv
lineag
rna
copi
lineag
b
rna
lineagespecif
probe
use
hmpv
assay
amplifi
viral
bacteri
respiratori
pathogen
show
specif
two
clinic
specimen
test
triplic
repeat
differ
run
gave
mean
cross
threshold
c
valu
respect
total
coeffici
variat
cv
suggest
good
overal
precis
assay
intraassay
variabl
two
specimen
interassay
variabl
studi
period
analysi
januari
march
respiratori
specimen
individu
patient
respiratori
outbreak
test
use
univers
probe
design
detect
lineag
b
hmpv
describ
section
analysi
data
show
specimen
posit
hmpv
give
overal
posit
rate
period
c
valu
posit
sampl
rang
repres
wide
distribut
viral
load
mean
c
valu
standard
deviat
specimen
type
posit
sampl
divers
includ
upper
respiratori
specimen
posit
specimen
lower
respiratori
specimen
posit
specimen
shown
tabl
agespecif
data
avail
sampl
posit
patient
rang
age
day
year
major
posit
specimen
patient
less
year
shown
fig
total
sampl
test
patient
month
month
age
respect
posit
rate
hmpv
significantli
higher
younger
age
group
compar
month
age
p
coinfect
respiratori
virus
rel
common
n
hmpvposit
sampl
analyz
anoth
detect
viru
n
posit
two
addit
viral
target
nucleic
acid
test
specimen
coinfect
identifi
parainfluenza
viru
adenoviru
common
virus
identifi
respect
follow
influenza
b
rsv
influenza
nine
sampl
posit
three
viral
target
includ
hmpv
three
adenoviru
influenza
b
three
adenoviru
parainfluenza
one
sampl
influenza
b
parainfluenza
parainfluenza
rsv
adenoviru
rsv
tendenc
toward
coinfect
younger
individu
year
age
reach
statist
signific
p
dual
infect
detect
specimen
upper
lower
respiratori
specimen
outbreak
defin
epidemiolog
link
case
respiratori
ill
identifi
medic
offic
health
communic
diseas
unit
within
respect
health
region
studi
total
specimen
outbreak
longterm
assist
care
center
mean
patient
age
year
school
mean
patient
age
year
test
hmpv
sampl
posit
outbreak
associ
hmpv
infect
nine
outbreak
hmpv
etiolog
agent
found
influenza
b
hmpv
identifi
four
outbreak
influenza
hmpv
identifi
four
outbreak
parainfluenza
hmpv
found
three
outbreak
adenoviru
isol
addit
etiolog
agent
one
outbreak
four
outbreak
associ
two
respiratori
virus
includ
hmpv
presum
repres
divers
cocircul
virus
commun
eight
hmpvposit
outbreak
school
long
term
assist
care
center
although
number
categori
high
enough
assess
statist
signific
studi
season
distribut
hmpv
geograph
area
percentag
hmpv
infect
re
fig
result
illustr
increas
hmpv
activ
winter
month
decemb
januari
februari
amplif
sequenc
base
pair
fragment
f
gene
randomli
select
hmpv
posit
show
five
virus
belong
lineag
lineag
five
f
gene
sequenc
lineag
ident
submit
sequenc
given
genbank
access
base
differ
refer
sequenc
result
sequenc
ident
four
hmpv
lineag
virus
sampl
obtain
decemb
geograph
locat
one
virus
isol
patient
differ
citi
march
sequenc
belong
lineag
diverg
lineag
base
pair
variat
percent
ident
compar
refer
sequenc
genbank
access
number
sequenc
list
phylogenet
tree
illustr
relationship
hmpv
partial
f
gene
sequenc
shown
fig
human
metapneumoviru
emerg
pathogen
associ
symptom
rang
mild
upper
respiratori
tract
infect
sever
pneumonia
exacerb
asthma
chronic
obstruct
pulmonari
diseas
alto
esper
et
al
fouchier
et
al
kahn
van
den
hoogen
et
al
b
william
et
al
serolog
studi
show
viru
circul
undetect
human
least
year
van
den
hoogen
et
al
thu
import
pathogen
essenti
obtain
better
understand
associ
diseas
risk
factor
two
major
lineag
hmpv
lineag
repres
two
sub
lineag
boivin
et
al
van
den
hoogen
et
al
b
two
genet
lineag
antigen
highli
relat
serotyp
distinct
macphail
et
al
skiadopoulo
et
al
van
den
hoogen
et
al
b
hinder
serolog
detect
differenti
base
antibodi
assay
lineag
howev
differenti
use
molecular
method
develop
appli
realtim
pcr
test
detect
hmpv
respiratori
sampl
use
assay
determin
percentag
season
distribut
hmpv
infect
respiratori
specimen
commun
assess
associ
commun
respiratori
outbreak
nucleic
acid
amplificationbas
protocol
detect
hmpv
publish
base
f
nucleoprotein
n
phosphoprotein
p
polymeras
l
gene
agapov
et
al
boivin
et
al
chan
et
al
cote
et
al
ebihara
et
al
esper
et
al
falsey
et
al
gerna
et
al
kuyper
et
al
mackay
et
al
maertzdorf
et
al
stockton
et
al
van
den
hoogen
et
al
studi
shown
sequenc
divers
f
gene
patient
sampl
limit
agapov
et
al
galiano
et
al
kuyper
et
al
van
den
hoogen
et
al
b
winther
et
al
assay
highli
sensit
detect
hmpv
sensit
compar
assay
perform
use
lineag
lineag
b
univers
probe
although
compar
newli
develop
assay
previous
report
limitofdetect
studi
suggest
assay
compar
sensit
report
nucleic
acid
detect
method
hmpv
primer
probe
design
studi
allow
differenti
well
simultan
detect
major
lineag
b
lineagespecif
detect
facilit
molecular
epidemiolog
studi
hmpv
design
characterist
assay
would
allow
detect
four
lineag
preliminari
sequenc
analysi
posit
sampl
reveal
lineag
b
repres
popul
sequenc
isol
determin
occurr
differ
lineag
geograph
area
incid
hmpv
report
differ
part
world
use
convent
realtim
rtpcr
method
vari
ebihara
et
al
kuyper
et
al
mullin
et
al
peiri
et
al
viazov
et
al
result
studi
consist
report
literatur
observ
frequenc
hmpv
infect
respiratori
specimen
overal
patient
rang
age
day
year
high
test
specimen
januari
note
posit
rate
could
underestim
dfaposit
sampl
would
test
hmpv
nat
accord
current
diagnost
test
algorithm
median
age
hmpv
infect
report
vari
month
kuyper
et
al
mullin
et
al
william
et
al
howev
two
studi
investig
pediatr
popul
one
includ
adult
age
year
data
show
median
age
month
indic
higher
incid
hmpv
infect
young
less
month
age
data
show
higher
activ
hmpv
winter
month
decemb
januari
februari
fewer
sampl
test
earli
thu
peak
hmpv
activ
evid
season
previou
report
shown
peak
hmpv
infect
month
februari
april
variou
canadian
provinc
bastien
et
al
boivin
et
al
month
januari
may
unit
state
agapov
et
al
boivin
et
al
esper
et
al
kuyper
et
al
mullin
et
al
william
et
al
human
metapneumoviru
activ
shown
peak
month
june
januari
argentina
galiano
et
al
april
hong
kong
peiri
et
al
februari
itali
april
japan
kaida
et
al
season
hmpv
may
thu
vari
geograph
continu
surveil
number
year
help
understand
pattern
suggest
hmpv
circul
predominantli
late
winter
spring
temper
climat
howev
detect
throughout
year
lower
level
kahn
coinfect
respiratori
virus
found
high
proport
commun
acquir
case
hmpv
common
coinfect
virus
parainfluenza
viru
adenovirus
influenza
b
viru
rsv
influenza
order
preval
tendenc
toward
higher
coinfect
rate
patient
less
year
age
report
suggest
rsv
influenza
preval
coinfect
agent
kuyper
et
al
viazov
et
al
base
data
coinfect
seem
depend
common
virus
circul
commun
higher
proport
coinfect
note
upper
respiratori
specimen
one
reason
could
nasopharyng
sampl
common
type
collect
children
patient
lower
respiratori
sampl
submit
unselect
may
includ
individu
diseas
process
viral
infect
thu
dilut
rate
identifi
pathogen
specimen
type
addit
collect
bal
specimen
includ
salin
instil
suction
process
could
dilut
viral
load
sampl
increas
use
sensit
nat
respiratori
virus
poorli
detect
tradit
method
facilit
identif
multipl
virus
singl
sampl
realtim
pcr
assay
use
resolv
respiratori
infect
previous
unknown
etiolog
present
acut
infect
context
outbreak
perform
ongo
surveil
hmpv
analysi
data
multipl
respiratori
season
prove
valuabl
understand
hmpv
epidemiolog
